
IBM remains a Buy despite stock pullback and deal delays, with Q3 results on Oct 21 as key catalyst.
IBM's stock has dropped about 5% without new earnings reports, mainly due to delays in closing major mainframe and software deals expected by year-end. The company aims to meet its operating margin expansion target through productivity gains, despite...





